Quent Capital’s Guardant Health GH Stock Holding History

Quent Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4K	Buy	136 +4	+3%	+$435	﹤0.01%	1062
2026 Q1	$12.2K	Hold	132	–	–	﹤0.01%	1112
2025 Q4	$13.5K	Hold	132	–	–	﹤0.01%	1092
2025 Q3	$8.25K	Buy	+132	New	+$7.18K	﹤0.01%	1060
2025 Q2	–	Sell	-132	Closed	-$5.62K	–	664
2025 Q1	$5.62K	Sell	132 -10	-7%	-$431	﹤0.01%	995
2024 Q4	$4.34K	Hold	142	–	–	﹤0.01%	1069
2024 Q3	$3.26K	Hold	142	–	–	﹤0.01%	1171
2024 Q2	$4.1K	Buy	142 +16	+13%	+$373	﹤0.01%	1119
2024 Q1	$2.6K	Hold	126	–	–	﹤0.01%	1200
2023 Q4	$3.41K	Buy	126 +50	+66%	+$1.31K	﹤0.01%	1134
2023 Q3	$2.25K	Sell	76 -4	-5%	-$141	﹤0.01%	1164
2023 Q2	$2.86K	Hold	80	–	–	﹤0.01%	1142
2023 Q1	$1.88K	Buy	80 +70	+700%	+$2K	﹤0.01%	1173
2022 Q4	$272	Sell	10 -55	-85%	-$2.52K	﹤0.01%	1273
2022 Q3	$3K	Hold	65	–	–	﹤0.01%	1042
2022 Q2	$3K	Sell	65 -42	-39%	-$2.08K	﹤0.01%	1012
2022 Q1	$7K	Buy	107 +52	+95%	+$3.56K	﹤0.01%	976
2021 Q4	$6K	Buy	+55	New	+$5.69K	﹤0.01%	892

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quent Capital's GH Position: Q2 2026 in Review

Quent Capital increased its Guardant Health (GH) stake by 3% in Q2 2026, buying an estimated $435 and bringing the position to 136 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Quent Capital first reported a position in GH in Q4 2021 and has held it in 18 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Quent Capital held 136 shares of Guardant Health worth $20.4K as of Q2 2026.
Quent Capital bought 4 Guardant Health shares in Q2 2026, an estimated $435.
Guardant Health made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1062 holding.
Quent Capital first reported a position in Guardant Health in Q4 2021 and has held it in 18 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.